Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Pancreatic Ductal Adenocarcinoma”

276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 276 results

Large-scale testing (Phase 3)Looking for participantsNCT07076121
What this trial is testing

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb 470
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06168812
What this trial is testing

Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic CarcinomaPancreatic Ductal Adenocarcinoma+3 more
Memorial Sloan Kettering Cancer Center 29
Early research (Phase 1)Looking for participantsNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 70
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03193190
What this trial is testing

Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Who this might be right for
Pancreatic Adenocarcinoma
Hoffmann-La Roche 341
Very early researchActive Not RecruitingNCT04862260
What this trial is testing

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more
CHU de Quebec-Universite Laval 3
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Testing effectiveness (Phase 2)Looking for participantsNCT07235202
What this trial is testing

MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Shenzhen Majory Biotechnology Co., Ltd. 45
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Testing effectiveness (Phase 2)Ended earlyNCT02732938
What this trial is testing

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 22
Early research (Phase 1)WithdrawnNCT04632199
What this trial is testing

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal Cancer
Ipsen
Early research (Phase 1)Looking for participantsNCT06882746
What this trial is testing

Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Who this might be right for
Colorectal CarcinomaGastric CarcinomaPancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 135
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Large-scale testing (Phase 3)Not Yet RecruitingNCT07336953
What this trial is testing

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
West China Hospital 198
Not applicableNot Yet RecruitingNCT07014254
What this trial is testing

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Adenocarcinoma of the StomachColorectal Cancer Metastatic+1 more
Xijing Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT05360264
What this trial is testing

TailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma Recurrent
Luca Cardone 7
Load More Results